Clinical trialNCT01680835CompletedInterventional

EverFlex Post Approval Study

SponsorMedtronic EndovascularEnrollment108Lower Extremity Arterial DiseasePeripheral Arterial Disease

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This post-approval study is designed to confirm the long-term safety and effectiveness of the EverFlex™ Self-Expanding Stent System for the treatment of atherosclerotic superficial femoral artery (SFA) and proximal popliteal arteries.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Jon S Matsumura, MD
University of Wisconsin, Madison
Principal Investigator
clinicaltrials.gov ↗
Krishna Rocha-Singh, MD
Prairie Heart Institute
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

St. Luke'S Medical Center
Phoenix, Arizona, United States
Memorial Medical Center
Modesto, California, United States
Sutter Memorial Hospital
Sacramento, California, United States
Christiana Care Health Services
Newark, Delaware, United States
First Coast Cardiovascular Institute, P.A.
Jacksonville, Florida, United States
Augusta Vascular Center
Augusta, Georgia, United States
Dupage Medical Group
Downers Grove, Illinois, United States
Rockford Cardiovascular Associates
Rockford, Illinois, United States
Central Iowa Hospital Corporation
Des Moines, Iowa, United States
Cardiovascular Solutions, Llc
Shreveport, Louisiana, United States
Sparrow Hospital
Lansing, Michigan, United States
Mercy Hospital/metropolitan Cardiology Consultants
Coon Rapids, Minnesota, United States
Deborah Heart and Lung Center
Browns Mills, New Jersey, United States
Wake Heart Research
Raleigh, North Carolina, United States
Oklahoma Heart Institute
Tulsa, Oklahoma, United States
Lankenau Institute for Medical Research
Bryn Mawr, Pennsylvania, United States
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
Black Hills Cardiovascular Research
Rapid City, South Dakota, United States
Sanford Research
Sioux Falls, South Dakota, United States
Premier Surgical Associates
Knoxville, Tennessee, United States
the University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
Bellin Memorial Hospital
Green Bay, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 14 Jan 2013
Primary completion: 23 Oct 2018
Completion: 4 Feb 2019
Last update posted: 26 Dec 2019
Registered enrollment: 108
Registry id: NCT01680835

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.